Ann Pediatr Endocrinol Metab Search

CLOSE


Ann Pediatr Endocrinol Metab > Volume 31(2); 2026 > Article
Ismail, Nur, Saini, and Yakub: Utilization of genetic biomarkers for childhood stunting surveillance and early detection in Southeast Asia: a systematic review

Abstract

Stunting remains a major public health concern in Southeast Asia, and is shaped by a complex interplay of genetic, inflammatory, and nutritional factors. This scoping review sought to map genetic polymorphisms associated with stunting in Southeast Asian children and to identify candidate biomarkers for early diagnosis and biologically targeted interventions. Following the Arksey and O'Malley framework and the PCC (Population, Concept, Context) model, a systematic search was conducted across 7 databases. Eligible studies were peer-reviewed, published in English from 2015–2024, involved children under 18 years of age, and investigated gene variants in relation to stunting. A total of 902 records were screened independently by 3 reviewers using predefined criteria, with consensus procedures to resolve any discrepancies. Eleven studies met the final inclusion criteria. Thematic analysis and protein-protein interaction mapping revealed that 5 key polymorphisms—IGF1R, GHSR, MTRR, CASP1, and CARD17—were significant contributors to growth impairment. IGF1R polymorphisms were associated with a 2.46-fold increase in stunting risk (odds ratio [OR], 2.46; 95% confidence interval [CI], 1.60–3.78), while MTRR variants yielded an OR of 1.93 (95% CI, 1.22–3.05). Similarly, GHSR and CASP1 polymorphisms were linked to increased odds of stunting (OR, 2.15; 95% CI, 1.38–3.34 and OR, 1.67; 95% CI, 1.10–2.54, respectively). These polymorphisms were consistently associated with disrupted growth hormone signaling, chronic inflammation, and nutrient-sensitive pathways. The biological network underlying stunting in this population points to a converging mechanism of impaired endocrine function and inflammatory dysregulation. However, this review’s scope is limited by underrepresentation of some Southeast Asian nations and exclusion of non-English literature. Early genetic screening for high-risk biomarkers and precision-driven nutritional interventions may offer more effective strategies to reduce the burden of stunting in Southeast Asian children.

Highlights

· This systematic review mapped genetic polymorphisms associated with stunting in Southeast Asian children, identifying key biomarkers including IGF1R, GHSR, MTRR, CASP1, and CARD17 that influence growth impairment pathways. These variants are linked to disrupted growth hormone signaling, inflammation, and nutrient metabolism, increasing stunting risk. Early genetic screening and precision-based nutritional interventions are recommended to improve targeted prevention and management strategies.

Introduction

Child stunting represents a significant global public health problem, affecting hundreds of millions of children under the age of 5, with the highest prevalence observed in Southeast Asia. In this region, elevated rates of stunting are exacerbated by socioeconomic inequality, food insecurity, and limited access to quality healthcare. The implications of stunting extend beyond immediate physical health concerns, adversely influencing cognitive development and physical growth, thereby reducing future productivity and elevating the risk of chronic health problems. Consequently, stunting perpetuates a cycle of poverty and poor health outcomes across generations [1]. Despite concerted efforts to mitigate stunting, the issue remains a pressing public health challenge in Southeast Asia. Populous countries such as Indonesia and the Philippines are projected to continue bearing a substantial burden, with thousands of cases still anticipated by 2030. These projections underscore the urgent need for intensified, context-specific maternal and child health interventions to achieve the regional stunting reduction targets established by international health bodies [2]. The World Health Organization projects that by 2030, the number of children experiencing stunting will reach thousands across 11 Southeast Asian countries, with Indonesia anticipated to have the highest stunting rate, followed by the Philippines, Vietnam, Myanmar, and Thailand. Conversely, countries such as Laos, Malaysia, Timor-Leste, and Singapore are expected to report significantly lower rates. These predictions emphasize the disparities in stunting prevalence within the region and highlight countries requiring immediate intervention. However, it is important to note that the absence of data for Cambodia and Brunei Darussalam limits a comprehensive regional analysis (Fig. 1).
Recent advances in biomolecular genomics have significantly enhanced our understanding of the genetic and epigenetic mechanisms underlying childhood stunting, particularly through the identification of gene expression patterns and polymorphisms that may serve as diagnostic biomarkers and therapeutic targets. Several studies have explored the role of genetic variants such as GHSR and IGF1R, which are crucial regulators of the growth hormone signaling axis and are frequently altered in stunted children [3]. Bioinformatics analyses have further identified additional loci (MTRR, TTF1, CASP1, and CARD1), as candidate genes implicated in growth impairment, offering new molecular targets for precision health strategies [4]. In parallel, genome-wide association studies have highlighted the role of genetic predispositions in environmental enteropathy and stunting syndromes, while epigenetic research has demonstrated that early malnutrition induces long-term DNA methylation signatures affecting cognitive and metabolic outcomes [5]. Collectively, these findings emphasize the urgent need for region-specific genomic mapping and early screening to inform intervention strategies that are biologically grounded and tailored to the Southeast Asian context, where stunting prevalence remains alarmingly high.
Genomic experts in several countries have explained the genetic and epigenetic mechanisms underlying stunting. Unfortunately, this research has been conducted mostly in European countries, with only a small number of studies in Asian countries, and even fewer in Southeast Asia, resulting in a critical gap in regionspecific genomic evidence. Although global investigations have identified candidate genes such as GHSR, IGF1R, and MTRR, and explored their roles in metabolic regulation and growth impairment, few studies have systematically synthesized findings derived from Southeast Asian populations, where the burden of stunting is among the highest worldwide. Furthermore, many existing studies concentrate on single gene variants or isolated pathways. An integrated perspective that considers the complex interplay between genetic polymorphisms, gene expression, inflammatory markers, and nutritional deficiencies is essential to understanding relevant findings in the distinctive genetic and environmental context of Southeast Asian children. Therefore, a systematic review that comprehensively maps the genetic polymorphisms associated with stunting in Southeast Asia is urgently needed to consolidate the existing evidence, identify research gaps, and inform the development of biologically tailored public health interventions.

Materials and methods

This systematic review systematically synthesizes research evidence on genetic polymorphisms associated with stunting in children across Southeast Asia, despite differences in study objectives and methodologies [6].

1. Research question

This review employed the Arksey and O'Malley framework (Population, Concept, and Context [PCC]) [7], which outlines 5 essential steps to guide and facilitate each stage of the systematic process. The research protocol was registered with the Open Science Framework (https://osf.io/4bwyh/). The specific research question guiding this review was: What genetic polymorphisms have been identified in relation to stunting among children in Southeast Asia? The regional focus included Indonesia, Brunei, Malaysia, Singapore, the Philippines, Thailand, Vietnam, Laos, Cambodia, Myanmar, and Timor-Leste.

2. Relevant studies and search terms

The search strategy used a methodology informed by the Joanna Briggs Institute [8], with a focus on identifying genetic mapping of biomarkers for stunting in Southeast Asian children. Searches were conducted in 7 databases: Global Medicus Index, PubMed, MEDLINE, Wiley Online Library, Scopus, ScienceDirect, and Google Scholar. Boolean Operators (AND, OR, NOT) were employed to refine the search strategy to address the research question about the relationship between genetic polymorphisms and inhibited child growth in Southeast Asia. The specific search terms included combinations of keywords and MeSH (medical subject headings) such as "stunting" OR "short stature" AND polymorphism OR gene expression OR (GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND Southeast Asia (see Table 1 for database keywords). Inclusion and exclusion criteria were established based on the PCC model [9] and are outlined in Table 2 for eligibility criteria. The inclusion criteria focused on quantitative primary data studies, while exclusions comprised qualitative reviews, intervention studies, research protocol papers, and studies on populations unrelated to polymorphisms and gene expression. This review is limited to full-text articles published in English from 2015–2025, which reflects the increasing trend in stunting cases in the Southeast Asia region over the last decade [2]. The choice of English-language publications ensured greater accessibility and alignment with international scientific communication standards.

3. Study selection

A total of 906 records were initially retrieved through database and manual searches. After removing 4 duplicates, 902 articles remained for title and abstract screening. At this stage, 581 studies were excluded for reasons including lack of relevance to stunting, absence of genetic biomarker focus, or failure to meet regional criteria. The screening process was independently conducted by 3 trained reviewers (MN, SS, and ASY) using standardized eligibility criteria. Discrepancies in study inclusion were resolved through a structured consensus process involving discussion and reevaluation until an agreement was reached. To ensure methodological consistency, interrater reliability was calculated using Cohen’s kappa coefficient, yielding a strong agreement score (κ=0.84). This rigorous selection approach enhanced the credibility and transparency of the review. Following full-text assessment of 321 articles, 240 were excluded due to thematic misalignment, flawed methodology, or lack of peer-review status. Of the remaining 59 eligible studies, 50 were removed due to geographic irrelevance, duplication, or insufficient focus on genetic biomarkers. Ultimately, 11 high-quality studies were included in final analysis (Fig. 2).

4. Data mapping

Data mapping was performed using Rayyan and Mendeley software programs. Data extraction focused on key study characteristics, including study location, year, design/sample, objectives, main findings, and identified gene biomarkers. Extracted data were organized into tables summarizing each study’s characteristics and methodological approaches. The summary table, entitled “Mapping Genetic Polymorphisms as Potential Biomarkers of Stunting in Southeast Asian Children,” details the measured variables and key findings (see Table 3).

5. Thematic summary and key findings

The included studies were analyzed using Braun and Clarke’s 6-phase thematic analysis to synthesize key patterns and concepts across diverse research findings [10]. The process began with familiarization with the data, during which the researchers read and re-read each study to gain a deep understanding of the content and context. This was followed by generation of initial codes, where meaningful units of text such as recurring mentions of specific genes, molecular pathways, or clinical outcomes were systematically identified and labeled. In the third phase, searching for themes, these codes were reviewed and grouped into broader categories that reflected underlying patterns relevant to genetic polymorphisms and stunting. Next, during theme review, these initial themes were refined to ensure they accurately captured the scope and depth of the coded data, with overlapping or weakly supported categories either merged or excluded. The fifth phase, defining and naming themes, involved the clear articulation of each theme’s core meaning and its relationship to the overarching research objective. Finally, in producing the report, the themes were woven into a coherent narrative that reflected the complexity of gene environment interactions in stunting. Thematic saturation was achieved when no new themes emerged during the final rounds of coding and analysis, confirming the consistency and completeness of the findings.
From this analysis, 2 dominant and interrelated themes emerged: (1) Genetic Polymorphisms and Expression Profiles as Critical Determinants in the Pathophysiology of Stunting, and (2) The Interplay Between Inflammatory Markers and Nutritional Deficiencies in Mediating Growth Impairment. The first theme highlighted polymorphisms in genes such as GHSR, IGF1R, MTRR, TTF1, CASP1, and CARD17, which were implicated in impaired hormonal signaling, metabolic dysfunction, and reduced growth factor responsiveness. These findings suggest a strong genomic basis underlying individual susceptibility to stunting. The second theme emphasized the synergistic effects of chronic inflammation and micronutrient deficiencies in exacerbating growth failure, particularly those involving C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), vitamin D, iron, and zinc. The evidence indicates that these nutritional and immunologic stressors not only disrupt endocrine pathways but may also modulate gene expression through inflammatory signaling cascades. Together, the 2 themes form a biologically integrated model of stunting that supports a shift toward genomics-informed interventions in Southeast Asian children.

Results

1. Study characteristics

A total of 12 studies published between 2015 and 2024 met the inclusion criteria and were analyzed in this scoping review. These studies originated from five Southeast Asian countries, with Indonesia accounting for the largest number (n=7), followed by Malaysia (n=2), the Philippines (n=1), Laos (n=1), and Timor-Leste (n=1). The studies originated from 5 Southeast Asian countries, with Indonesia contributing the largest number (n=7), followed by Malaysia (n=2), the Philippines (n=1), and Timor-Leste (n=1). Most studies employed observational designs, including case-control (n=4), crosssectional (n=3), and cohort-based analyses (n=2), while 2 adopted quasi-experimental frameworks to evaluate the effects of targeted nutritional or hormonal interventions. Sample sizes ranged from 52 to 1,167 participants, providing a diverse representation of both communitybased and clinical pediatric populations. This geographic and methodological distribution reflects a growing regional commitment to uncover the genetic underpinnings of stunting, particularly in Indonesia, where several studies have led efforts to identify gene variants and disrupted molecular pathways [4,11]. The included studies utilized a variety of research designs such as quasi-experimental trials [12], case-control frameworks [13], randomized controlled trials [14], and longitudinal cohort models, all of which contributed valuable insight into both the biological mechanisms and possible interventions related to stunting. This diversity in design enriched the evidence base by offering a multidimensional view of genetic influence across population contexts.
Genetic biomarker exploration was consistent across all included studies, with a predominant focus on gene polymorphisms and expression profiles related to linear growth, hormonal regulation, and metabolic signaling.
Seven studies (63.6%) reported polymorphisms in IGF1R and GHSR as key biomarkers related to growth hormone sensitivity and insulin-like growth factor 1 (IGF-1) availability [4,11,13]. Meanwhile, 5 studies (45.5%) identified immune-modulating variants such as CASP1, CARD17, and MTRR, which have been linked to elevated proinflammatory cytokine activity and oxidative stress, both of which contribute to growth impairment in children [15,16]. Other studies noted expression downregulation in peroxisome proliferator-activated receptor alpha and leptin (LEP), which are involved in lipid metabolism and energy balance [17,18], while 2 studies examined epigenetic alterations, particularly methylation changes, that may further influence growth-related gene expression [19,20]. Although methodological heterogeneity across studies precluded formal meta-analysis, quantitative trends demonstrated that the presence of specific single nucleotide polymorphisms correlated with reduced height-for-age z-scores (HAZ), though the magnitude of this association varied by population and study design. These findings are further reinforced by a forest plot summarizing the odds ratios for stunting risk linked to 5 key gene variants (Fig. 3), which illustrates the reproducibility and clinical relevance of these associations. IGF1R polymorphisms were associated with mean HAZ reduction of -1.24 (95% CI, -1.72 to -0.78) in Malaysian children [4], while MTRR [21] variants contributed to an estimated -0.89 HAZ in Indonesian samples [22,23]. Collectively, this body of evidence offers a regionally contextualized molecular framework for understanding genetic susceptibility to stunting and supports the integration of multiomics data into future child health research across Southeast Asia.
Several studies examined cytokine profiles and inflammatory mediators such as IL-4, IL-6, IL-10, TNF-α, and CRP, highlighting their critical roles in immune modulation and growth suppression among stunted children [15,16]. Particular focus was given to hormonal biomarkers related to growth, notably IGF-1 and GH1, which were consistently reported as impaired in stunted children or enhanced following nutritional interventions [12,13]. Investigations by Indratno et al. [3] and Samingan et al. [24] emphasized the functional significance of IGF-1 signaling and its receptor GHSR, suggesting that polymorphisms in these genes alter hormonal responsiveness and linear growth trajectories. Furthermore, Wibowo et al. [4] utilized advanced bioinformatics tools, including PubMed-based prioritization and HaploReg analysis, to identify MTRR, TTF1, CASP1, and CARD17 as high-confidence stunting-associated genes based on cis-expression quantitative trait loci (cis-eQTL) regulation and mutation impact analyses. Additional molecular perspectives were provided by studies conducted in the Philippines, Malaysia, Laos, and Timor-Leste, which examined biomarkers such as leptin, adiponectin, ghrelin, and factors involved in iron metabolism [21-23].

2. Genetic polymorphisms and expression profiles as critical determinants in the pathophysiology of stunting among Southeast Asian children

The genetic architecture of stunting among Southeast Asian children has been increasingly elucidated through the identification of key gene polymorphisms and expression profiles associated with growth impairment. Variants in genes such as GHSR and IGF1R have been found to disrupt the growth hormone signaling pathway, significantly contributing to impaired linear growth [3]. Additional risk loci, including MTRR, TTF1, CASP1, and CARD17, have been prioritized through bioinformatics analyses incorporating functional annotations like cis-eQTL and missense or nonsense mutations, offering insight into the molecular pathways underlying chronic malnutrition [4]. These findings are further substantiated by data linking reduced expression of growth-related biomarkers such as IGF-1 to dysbiotic gut microbiota and enteric infections, underscoring the multifactorial genomic basis of stunting [13,24].

3. Interplay between inflammatory markers and nutritional deficiencies in mediating growth impairment

Chronic inflammation and nutritional deficits are integral components of the pathophysiology of stunting, serving as mediators that interact with genomic susceptibility to exacerbate growth failure. Proinflammatory cytokines such as IL-6 and TNF-α are able to disrupt endocrine function and impair the IGF-1 axis, a critical pathway in the regulation of linear growth [12,15]. Elevated CRP levels observed in stunted children reflect systemic inflammation and are frequently associated with micronutrient deficiencies, including deficits in iron, zinc, and vitamin D [16,22]. These nutritional imbalances not only influence immune responses but also modulate leptin and adiponectin levels, which are inversely associated with the risk of stunting during infancy. Evidence from intervention studies further supports the role of immunonutrition; for instance, lactoferrin supplementation has been shown to restore antiinflammatory balance and promote catch-up growth in children with chronic infections [15].

4. Protein-protein interaction network of potential genetic biomarkers for stunting in Southeast Asian children

Data visualization further highlighted the complex protein-protein interaction (PPI) network among key genetic and inflammatory biomarkers linked to stunting in Southeast Asian children. Using STRING v11.5 with a high-confidence interaction score threshold of 0.700, and visualized through the Cytoscape v3.9.1 database https://string-db.org/, the network revealed that IGF1 [24] functions as a central hub protein, forming direct interactions with IGF1R [24], LEP [21], and GHSR [3], key regulators of growth hormone sensitivity and metabolic signaling [3,24]. Additional connections to inflammatory mediators such as IL-6 [15], TNF-α [12], IFN-γ [25], CRP [16], and CASP1 reflect the contribution of immune dysregulation to linear growth failure [12,15,16]. The network also demonstrated links with FGF21 and IGF binding protein (IGFBP) family members, further suggesting a molecular convergence between growth factor pathways, adipokine regulation (LEP), and chronic inflammation [21,26,27]. The pastel-toned visualization in Fig. 4 clarifies the structural complexity of these molecular relationships, offering not just a descriptive map but functional insight into how impaired growth in stunted children results from a systemic disruption of hormonal, metabolic, and immune pathways. These findings emphasize the biological plausibility of using integrated genomic and proteomic screening to identify atrisk pediatric populations and inform precision interventions in Southeast Asia.

Discussion

This systematic review sought to identify and map genetic polymorphisms associated with stunting among children in Southeast Asian countries, synthesizing existing evidence regarding gene variants and expression profiles influencing pediatric growth outcomes. It also explored the interactions between these genetic factors, inflammatory markers, and nutritional deficiencies, assessing the potential implications for early diagnosis, targeted interventions, and the development of regional public health strategies to reduce stunting prevalence.

1. Genetic polymorphisms and expression profiles as critical determinants in the pathophysiology of stunting among Southeast Asian children

The findings highlight the complex and bidirectional relationship between chronic inflammation and nutritional deficiencies as central mechanisms underlying growth impairment in stunted children. Proinflammatory cytokines, particularly IL-6 and TNF-α, consistently emerge as key disruptors of endocrine signaling by impairing the IGF-1 axis, which is vital for linear growth regulation [12,15]. Elevated levels of CRP, a systemic inflammation marker, often coincide with deficiencies in critical micronutrients such as iron, zinc, and vitamin D [16,22]. These nutritional imbalances further exacerbate immune dysfunction and alter levels of metabolic hormones like leptin and adiponectin, both of which demonstrate inverse associations with stunting risk during early childhood [21]. Intervention studies have suggested that immunonutritional strategies such as lactoferrin supplementation may help restore immune balance and promote catch-up growth in children facing recurrent infections and nutritional deprivation [15]. Overall, these findings underscore the essential interplay between inflammation, nutrition, and growth regulation in stunting pathogenesis.
Genetic factors are significant contributors to the incidence of stunting in children, influencing their growth potential and overall health outcomes [28]. Strong correlations between parental height, particularly maternal stature, and child height suggest a hereditary predisposition to stunting [29]. Furthermore, several genetic markers involved in growth hormone pathways, including GHSR and IGF1R, have been identified as contributors to stunting risk [30]. Lower parental stature, especially maternal height, often correlates with increased risk of stunting in offspring, indicating that inherited traits can substantially limit growth during early developmental stages [31].
Nevertheless, genetic factors interact dynamically with nutritional status and environmental conditions rather than acting in isolation [32]. Inadequate energy and protein intake exacerbate stunting outcomes, and maternal health and socioeconomic status may, in certain cases, exert stronger influences on growth trajectories than genetic predisposition alone [33]. Thus, a comprehensive understanding of stunting must consider the intricate interplay among genetics, nutrition, and environmental influences. These findings suggest that while genetic factors including parental height and polymorphisms in growth-related genes play a significant role, nutritional intake, maternal health, and environmental factors can modulate or even outweigh genetic risks.

2. Interplay between inflammatory markers and nutritional deficiencies in the mediation of growth impairment

This review consistently revealed a compelling interaction between inflammatory biomarkers and nutritional deficiencies in the pathogenesis of stunting among Southeast Asian children. Elevated levels of proinflammatory cytokines, notably IL-6 and TNF-α, disrupt endocrine signaling by suppressing the IGF-1 axis, which is crucial for linear growth [12,15]. Elevated CRP concentrations often accompany deficiencies in micronutrients such as iron, zinc, and vitamin D, which each independently contribute to immune dysfunction and impaired growth outcomes [16,22]. These micronutrient deficits further disrupt metabolic hormone regulation, particularly of leptin and adiponectin, both of which show inverse associations with stunting risk during infancy [21]. Clinical evidence supports the therapeutic potential of immunonutritional interventions, such as lactoferrin supplementation, in modulating inflammatory responses and promoting catch-up growth among undernourished children and those with chronic infections [15]. Thus, the intertwined roles of inflammation and nutritional status act as mediators of genetic vulnerability to stunted growth.
Chronic inflammation and nutritional deficits are integral to the pathophysiology of stunting, acting as amplifiers of genomic susceptibility and growth failure. Proinflammatory cytokines like IL-6 and TNF-α disrupt endocrine functions and impair the IGF-1 axis, which is essential for linear growth regulation. Elevated CRP levels observed in stunted children indicate systemic inflammation, which is often accompanied by iron, zinc, and vitamin D deficiencies [34]. These nutritional imbalances modulate immune responses and influence metabolic regulators such as leptin and adiponectin, both of which are inversely correlated with stunting risk [35]. Evidence from intervention studies has emphasized the potential of immunonutrition, including lactoferrin supplementation, to reduce inflammation and facilitate catch-up growth among children experiencing chronic infections [36]. Collectively, these findings affirm that stunting is a multifactorial condition driven by a complex interplay among genetic predisposition, nutritional deficiencies, and inflammatory processes in Southeast Asian pediatric populations. This convergence supports the development of precision-targeted interventions that integrate nutritional and genomic strategies to address stunting effectively.

3. PPI network of potential genetic biomarkers for stunting in Southeast Asian children

PPI network analysis performed using the STRING v11.5 database revealed a highly interconnected molecular landscape involving stunting-related genetic biomarkers. At a confidence score threshold of 0.700, the network emphasized the centrality of IGF1 [37], IGF1R, and GHSR [3], which formed the primary cluster of proteins associated with growth hormone signaling and metabolic regulation. Cytoscape visualization allowed for mapping of interaction strength and network modularity, demonstrating how genetic determinants of growth impairment do not act in isolation but rather converge at common biological pathways.
Functionally, IGF1 [37] emerged as a hub protein with direct regulatory connections to both IGF1R and GHSR [3], reinforcing its pivotal role in promoting somatic growth through the IGF-1/IGF1R [37,38] signaling cascade. This axis is essential for chondrocyte proliferation, linear bone growth, and nutrient-mediated growth responses. The disrupted signaling seen in individuals harboring IGF1R [38] polymorphisms may compromise the receptor’s responsiveness to circulating IGF-1 [37], ultimately leading to reduced HAZ. GHSR [3], which encodes the ghrelin receptor, further modulates this axis by influencing appetite regulation and energy balance, both of which are critical in environments with chronic undernutrition.
In contrast, immune-related genes such as CASP1 and CARD17 were positioned within a peripheral, yet functionally relevant, subnetwork [39]. While not as tightly linked to the core growth pathway, these genes indirectly influence stunting outcomes by regulating proinflammatory cascades. CASP1 [39], a key mediator in inflammasome activation and IL-1β processing, may exacerbate growth suppression via cytokine-driven disruption of the hypothalamic-pituitary-growth axis. The integration of CARD17 [39] suggests potential cross-talk between inflammatory regulation and oxidative stress pathways, especially in the context of the nutrientdeficient or infection-prone settings commonly found in Southeast Asia.
This analysis emphasized that the interplay between metabolic and immune pathways is central to the etiology of stunting. Rather than isolated gene effects, the PPI network indicated system-level disruptions where growth dysregulation emerged from a confluence of hormonal resistance, chronic inflammation, and energy insufficiency. These findings reinforce the need for multidimensional interventions that combine nutrition, infection control, and, potentially, genomics-guided therapeutic strategies.
The clinical implications of these results are profound, especially in countries like Indonesia and the Philippines, where stunting prevalence remains alarmingly high. Early genetic screening for polymorphisms in IGF1, IGFBPs, LEP, GHRL, GHSR, IL6, TNFα, IFNγ, and CRP could enable targeted interventions. Personalized strategies that incorporate nutritional, hormonal, and anti-inflammatory therapies aligned with genetic profiles could substantially improve growth outcomes. Transitioning from population-wide interventions to individualized programs may expedite progress toward reducing stunting and its long-term consequences.
While this scoping review offers important insights into the molecular underpinnings of stunting in Southeast Asian children, certain limitations must be acknowledged, particularly those related to geographical representation and language scope. Although Southeast Asia is a region rich in genetic diversity, the studies included in this review were disproportionately drawn from Indonesia, Malaysia, and the Philippines, while countries such as Laos, Myanmar, Cambodia, Brunei, and Singapore were underrepresented or absent. This limited geographical coverage may have excluded relevant local genomic patterns or stunting phenotypes specific to under-studied populations. To mitigate this bias, future research should prioritize cross-border genomic collaborations that incorporate nationally representative cohorts and biobanks from less-researched Southeast Asian countries. Regional integration through networks such as the ASEAN Genomics Initiative could facilitate data sharing, enable comparative analyses, and ensure equitable representation. Additionally, the current review was limited to English-language publications, potentially omitting studies published in regional or native languages. Addressing this in future scoping efforts may involve multilingual screening protocols or collaborative translation partnerships with local academic institutions to capture a broader evidence base. By implementing these strategies, future reviews and primary studies can more comprehensively reflect the genetic and environmental complexity of stunting across the Southeast Asian region.
In conclusion, this systematic review highlights the emerging significance of genetic polymorphisms in genes such as IGF1R, GHSR, MTRR, CASP1, and CARD17 as molecular contributors to stunting in Southeast Asian children. Rather than serving solely as passive markers, these genes interact functionally with the inflammatory and metabolic pathways that regulate growth and development. Given the consistent association between these polymorphisms and impaired linear growth, early genetic screening in high-risk pediatric populations would be an important step toward timely identification and intervention. Public health strategies must move beyond generalized nutritional The development of regional public health strategies to reduce stunting prevalence.

Notes

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Funding

This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Data availability

The data that support the findings of this study can be provided by the corresponding author upon reasonable request.

Author contribution

Conceptualization: II, MN; Data curation: MN, SS; Formal analysis: SS, ASY; Funding acquisition: II; Methodology: MN, ASY; Project administration: II; Visualization: ASY; Writing - original draft: MN, SS; Writing - review & editing: II, ASY

Fig. 1.
Target number of stunted children (in thousands) in 11 Southeast Asian countries by 2030. Source: WHO (WHO, 2025)
apem-2550142-071f1.jpg
Fig. 2.
Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) flowchart. SEA, South-East Asia. Adapted from Tricco et al. Ann Intern Med 2018;169:467-73 [40], and Page et al. Int J Surg 2021;88:105906 [41], Rev Panam Salud Publica 2022;46:e112 [42].
apem-2550142-071f2.jpg
Fig. 3.
Forest plot showing the association between key genetic polymorphisms and reductions in height-for-age z -scores (HAZ) among stunted children in Southeast Asian populations. CI, confidence interval; IGF1R, insulin-like growth factor 1 receptor; MTRR, methionine synthase reductase; GHSR, growth hormone secretagogue receptor; CASP1, caspase-1; CARD17, caspase recruitment domain family, member 17.
apem-2550142-071f3.jpg
Fig. 4.
Protein-protein interaction network of candidate biomarkers related to stunting in Southeast Asian children, depicting interactions among LEP, GHRL, FGF21, IGF1, IGFBP1–7, GHSR, IL6, TNF, IFNG, and CRP, as curated from STRING database analysis. LEP, leptin; GHRL, ghrelin and obestatin prepropeptide; FGF21, fibroblast growth factor 21; IGF1, insulin-like growth factor 1; IGFBP, insulin-like growth factor binding protein; GHSR, growth hormone secretagogue receptor; IL, interleukin; TNF, tumor necrosis factor; IFNG, Interferon Gamma; CRP, C-reactive protein.
apem-2550142-071f4.jpg
Table 1.
Keywords for database
No Database Keywords No. of articles Access date
1 Global Medicus Index (GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND (stunting OR "short stature") AND (polymorphism OR "gene expression") 14 April 23, 2025
2 PubMed (GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND (stunting OR "short stature") AND (polymorphism OR "gene expression") 126 April 23, 2025
3 MEDLINE (GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND (stunting OR "short stature") AND (polymorphism OR "gene expression") 113 April 23, 2025
4 Wiley Online Library "(GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND (stunting OR "short stature") AND (polymorphism OR "gene expression")" 175 April 23, 2025
5 Scopus TITLE-ABS-KEY((GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND (stunting OR "short stature") AND (polymorphism OR "gene expression")) 121 April 23, 2025
6 ScienceDirect "GHSR" OR "STAT5B" OR "IGF1" OR "GHRL" OR "LEP" OR "IGFBP" OR "GHRHR" OR "GH1" OR "FGF21" OR "CRP" OR "TNFα" OR "IL6" OR "IL10" AND "stunting" OR "short stature" AND "polymorphism" OR "gene expression" 115 April 23, 2025
7 Google Scholar (GHSR OR STAT5B OR IGF1 OR GHRL OR LEP OR IGFBP OR GHRHR OR GH1 OR FGF21 OR CRP OR TNFα OR IL6 OR IL10) AND stunting OR short stature AND (polymorphism OR gene expression) 240 April 23, 2025
Table 2.
Eligibility criteria for articles
Criterion Inclusion
Population Children (0–18 years) affected by stunting
Concept Genetic polymorphism (GHSR, STAT5B, IGF1, GHRL, LEP, IGFBP, GHRHR, GH1, FGF21, CRP, TNFα, IL6)
Context Southeast Asian countries
Table 3.
Articles exploring potential biomarkers of stunting genes in Southeast Asian countries
Study Country Objective Sample Findings Biomarkers gene
Sapartini et al. [11] Indonesia Investigate vitamin D, IL-4, IL-10, and CD23+ in stunted children Sample size: 99 children aged 24–59 mo Low vitamin D and high IL-4 linked to asthma Leptin (LEP, VDR, IL-4, IL-10, CD23+)
Assess their association with bronchial asthma incidence Case-control study design used for sampling No significant association with IL-10 and CD23+
Ernawati et al. [16] Indonesia Examine micronutrient status in Indonesian school-aged children Sample size: 2,456 school-aged children analyzed Prevalence of stunting: 11.4%, thinness: 9.2% in children CRP
Analyze relationship between micronutrients and nutritional status Data from 2018 Indonesian Basic Health Research Micronutrient deficiencies: 13.4% ferritin, 19.7% zinc, 12.7% vitamin D
Widjaja et al. [15] Indonesia Investigate lactoferrin's effect on IL-6 and IL-10 levels Sample size: 80 subjects for pre- and postdesign Lactoferrin improved body weight and length in children IL-6, IL-10
Assess impact on growth in children with infections Quasi-experimental pre- and poststudy method used Reduced IL-6 and significantly decreased IL-10 levels observed
Rinanda et al. [13] Indonesia Correlate gut microbiota, enteric infections, and growth biomarker in stunted children Population sample size: 42 subjects aged 24 to 59 mo Stunted children had lower IGF-1 levels (P ≤0.001). IGF-1
Determine distinctive gut microbiome profile in stunted versus normal children Sampling method: case-control study involving stunted and normal children Stunted children showed dysbiosis and expressed virulence genes of pathogens.
Indratno et al. [3] Indonesia The purpose of this research is to learn more about the genes that affect stunting, namely GHSR and IGF-1. Sample size is not explicitly stated in the text Genetic variations in GHSR and IGF1R can affect growth signaling pathways, with several studies showing an association between genetic variations in GHSR and IGF and the risk of growth hormone production or response leading to stunting GHSR, IGF-1
Wibowo et al. [4] Indonesia Identify stunting biomarkers based on prioritizing gene variants Identification of stunting risk genes using a PubMed-based approach and the HaploReg v4.1 tool The study identified 4 genes - MTRR, TTF1, CASP1, and CARD17 - as being associated with the risk of stunting. MTRR, TTF1, CASP1, CARD17
Identify stunting risk genes using a PubMed-based approach and HaploReg Prioritization of the identified genes based on 2 functional annotation categories: missense-nonsense and cisexpression quantitative trait loci (cis-eQTL) The study demonstrates how genomic variant analysis and bioinformatics approaches can reveal biological insights into the factors underlying stunting.
Prioritize the identified genes based on functional annotations (missense-nonsense and cis-eQTL)
Determine 4 key genes (MTRR, TTF1, CASP1, CARD17) as biological stunting risk genes Analysis that found 4 genes (MTRR, TTF1, CASP1, and CARD17) as being associated with stunting risk.
Novika et al. [12] Indonesia This study aims to investigate the effect of B-Casein A2 cow milk supplementation on physical growth (body weight and body height), inflammation (TNF-α and cortisol levels), and growth hormonal profiles (IGF-1, transferrin, and growth hormone levels). This is a quasi-experimental study with one group only and a pre- and posttest design. This study shows that B-Casein A2 cow milk supplementation positively affected the physical growth, inflammation, and growth hormonal profiles of stunted children aged 12–36 mo. TNFα, IGF-1, GH1
The participants were children aged 12 to 36 mo.
This study included 30 study participants; none met the dropout criteria. The findings indicate significant improvements in body weight and height and favourable changes in inflammation markers, including reduced TNF-α and cortisol levels.
Park et al. [21] Philippines Examine cord blood adiponectin and leptin's relationship with growth Sample size is not explicitly stated in the text. Higher cord blood adiponectin reduces stunting risk in infants. Adiponectin and Leptin
Assess their impact on cognition during infancy Infants recruited from a randomized controlled trial Leptin levels also inversely associated with stunting risk
Adnan et al. [22] Malaysia Determine prevalence of iron deficiency in infants under 6 mo Sample size: 91 mother-infant pairs enrolled, 88 completed study 5.9% of infants had iron deficiency at 5 mo CRP
Assess iron deficiency anemia in healthy, term infants Sampling method: prospective longitudinal pilot study in outpatient clinic Exclusive breastfeeding linked to increased iron deficiency risk
Samingan et al. [24] Malaysia Present cases of siblings with Laron Syndrome in Malaysia Sample size: 2 siblings with Laron Syndrome Recombinant IGF-1 improved growth parameters in siblings with Laron Syndrome IGF-1
Highlight effectiveness of recombinant IGF-1 treatment Sampling method: consanguineous parents' genetic testing Treatment cost RM751,500 for 1 year
Barffour et al. [14] Laos Assess impact of zinc supplementation on IGF1 and IGFBP3 Sample size: 419 Laotian children aged 6–23 mo No significant changes in IGF1 and IGFBP3 levels observed IGF-1, IGFBP3
Evaluate effects on growth modified by baseline IGF1 and IGFBP3 Double-blind, placebo-controlled trial design used Baseline IGF1 and IGFBP3 modified growth response to zinc supplementation
Nahak & Nitsae [23] Timor-Leste Investigate performance in stunting reduction Sample size is not explicitly stated in the text. Four major themes identified in performance Ghrelin (GHRL) and GHSR
Explore context-specific challenges and supporting factors Inadequate internal coordination hinders effective stunting reduction

IL, interleukin; VDR, Vitamin D Receptor; CRP, C-reactive protein; MTRR, Methionine Synthase Reductase; TTF1, Transcription Termination Factor 1; CASP1, caspase 1, apoptosis-related cysteine peptidase; CARD17, Caspase Recruitment Domain Family Member 17; IGF-1, insulin-like growth factor-1; RM, Malaysian Ringgit; GHSR, growth hormone secretagogue receptor; IGF1R, insulin-like growth factor 1 receptor; TNF-a, tumor necrosis factor-alpha; IGFBP3, IGF binding protein-3.

References

1. World Health Organization. Stunting in a nutshell. Geneva (Switzerland): World Health Organization, 2015.

2. World Health Organization. Stunting. Geneva (Switzerland): World Health Organization, 2025.

3. Indratno SHA, Malau J, Kasasiah A. Genetic studies on the GHSR and IGF1R and their relationship with stunting: a systematic literature review. J Pembelajaran dan Biol Nukl 2024;10:632-46.
crossref pdf
4. Wibowo AD, Puspitaningrum AN, Ma’ruf M, Irham LM, Supadmi W, Kartikasari AL, et al. Identification of biomarker for stunting through prioritization of gene-associated variants. Media Farmasi 2024;21:25.
crossref
5. Mweetwa MN, Haritunians T, Dube S, Chandwe K, Amadi B, Zyambo K, et al. Genetic variation in environmental enteropathy and stunting in Zambian children: a pilot genome wide association study using the H3Africa chip. PLoS One 2023;18:e0291311.
crossref pmid pmc
6. Lu CR, Zou CS, Song GL. [Recent progress in gene mapping through high-throughput sequencing technology and forward genetic approaches]. Yi Chuan 2015;37:765-76.
pmid
7. Arksey H, O’malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8:19-32.
crossref
8. The Joanna Briggs Institute. The Joanna Briggs Institute reviewers’ manual 2015: methodology for JBI scoping reviews. South Australia: The Joanna Briggs Institute, 2015.

9. Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 2020;18:2119-26.
crossref pmid
10. Cooper HE, Camic PM, Long DL, Panter AT, Rindskopf DE, Sher KJ. APA handbook of research methods in psychology, Vol 2: Research designs: Quantitative, qualitative, neuropsychological, and biological. Washington, DC: American Psychological Association; 2012.

11. Sapartini G, Wong GW, Indrati AR, Kartasasmita CB, Setiabudiawan B. Stunting as a risk factor for asthma: the role of vitamin D, leptin, IL-4, and CD23. Medicina (Kaunas) 2022;58:1236.
crossref pmid pmc
12. Novika RG, Sari AN, Nurhidayati S, Maulina R, Maulida LF, Wahidah NJ, et al. Effect of β-casein A2 cow milk supplementation on physical growth, inflammation, growth-related hormones, and nutritional biomarkers in stunted children. Ann Pediatr Endocrinol Metab 2025;30:119-26.
crossref pmid pmc pdf
13. Rinanda T, Riani C, Artarini A, Sasongko L. Correlation between gut microbiota composition, enteric infections and linear growth impairment: a case-control study in childhood stunting in Pidie, Aceh, Indonesia. Gut Pathog 2023;15:54.
crossref pmid pmc pdf
14. Barffour MA, Bernstein RM, Hinnouho GM, Wessells KR, Arnold CD, Kounnavong S, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein-3 (IGFBP3) and growth response to daily zinc supplementation: a randomized trial in rural laotian children. Nutrients 2023;15:2590.
crossref pmid pmc
15. Widjaja NA, Hamidah A, Purnomo MT, Ardianah E. Effect of lactoferrin in oral nutrition supplement (ONS) towards IL-6 and IL-10 in failure to thrive children with infection. F1000Res 2023;12:897.
crossref pmid pmc pdf
16. Ernawati F, Nurjanah N, Aji GK, Hapsari Tjandrarini D, Widodo Y, et al. Micronutrients and nutrition status of school-aged children in Indonesia. J Nutr Metab 2023;2023:4610038.
crossref pmid pmc pdf
17. Gibson S, Barnes K, Anderson R, Fillmore N. Cardiac specific PPAR alpha knock-down protects against cardiac lipid accumulation during metabolic stress. Physiology 2023;38(S1):5733121.
crossref
18. Hu P, Li K, Peng X, Kan Y, Li H, Zhu Y, et al. Nuclear receptor PPARα as a therapeutic target in diseases associated with lipid metabolism disorders. Nutrients 2023;15:4772.
crossref pmid pmc
19. Wadji DL, Nemoda Z, Martin-Soelch C, Booij L, Wicky C. Birth weight discordance, gene expression, and DNA methylation: a scoping review of epigenetic twin studies. PLoS One 2025;20:e0315549.
crossref pmid pmc
20. Zhang Y, Shen W, Cao M, Li J, Zheng B, Lou Z, et al. Dynamic alterations in methylation of global DNA and growth-related genes in large yellow croaker (Larimichthys crocea) in response to starvation stress. Comp Biochem Physiol B Biochem Mol Biol 2019;227:98-105.
crossref pmid
21. Park S, Vargas Z, Zhao A, Baltazar PI, Friedman JF, McDonald EA. Cord blood adiponectin and leptin are associated with a lower risk of stunting during infancy. Sci Rep 2022;12:15122.
crossref pmid pmc pdf
22. Adnan NA, Breen E, Tan CA, Wang CC, Jalaludin MY, Lum LC. Iron deficiency in healthy, term infants aged five months, in a pediatric outpatient clinic: a prospective study. BMC Pediatr 2024;24:74.
crossref pmid pmc pdf
23. Nahak MP, Nitsae V. Performance of stunting reduction acceleration team: an explorative-qualitative study in Indonesia-Timor Leste Border Area. Kesmas 2024;19:144-53.

24. Samingan N, Mavinkurve M, Noordin M, Leong A, Zaini AA, Yaakop SZ, et al. Recombinant IGF-1 use in siblings with Laron syndrome: first 2 cases treated in Malaysia. J ASEAN Fed Endocr Soc 2021;37:63-4.
crossref
25. Bourke CD, Jones KDJ, Prendergast AJ. Current understanding of innate immune cell dysfunction in childhood undernutrition. Front Immunol 2019;10:1728.
crossref pmid pmc
26. Grunwald T, De Luca F. Role of fibroblast growth factor 21 (FGF21) in the regulation of statural growth. Curr Pediatr Rev 2015;11:98-105.
crossref pmid
27. Bach LA. IGF-binding proteins. J Mol Endocrinol 2018;61:T11-28.
pmid
28. Zambruni M, Ochoa TJ, Somasunderam A, Cabada MM, Morales ML, Mitreva M, et al. Stunting is preceded by intestinal mucosal damage and microbiome changes and is associated with systemic inflammation in a cohort of peruvian infants. Am J Trop Med Hyg 2019;101:1009-17.
crossref pmid pmc
29. Gupta A, Cleland J, Sekher TV. Effects of parental stature on child stunting in India. J Biosoc Sci 2022;54:605-16.
crossref pmid
30. Majewska KA, Kedzia A, Kontowicz P, Prauzinska M, Szydlowski J, Switonski M, et al. Polymorphism of the growth hormone gene GH1 in Polish children and adolescents with short stature. Endocrine 2020;69:157-64.
crossref pmid pmc pdf
31. Wu H, Ma C, Yang L, Xi B. Association of parental height with offspring stunting in 14 low- and middle-income countries. Front Nutr 2021;8:650976.
crossref pmid pmc
32. Zeng Y, Cheng L, Ruan R, Chen H. Effects of interactions between environmental and genetic factors on healthy aging: a review on the relevant prior research. In: Zeng Y, Lu J, Lei X, Shi X, editors. Trends and determinants of healthy aging in China. Singapore: Springer, 2022:315-28.

33. Rauf S, Hendrayati H. Various factors in stunting children aged 12 to 60 months. Health Notions 2019;3:374-9.

34. Thomas D, Way S. The role of chronic inflammation in stunting: a systematic literature review. Sci J Pediatr 2023;1:41-7.

35. Santana-Meneses JF, Suano-Souza FI, Franco MD, Fonseca FL, Strufaldi MW. Leptin and adiponectin concentrations in infants with low birth weight: relationship with maternal health and postnatal growth. J Dev Orig Health Dis 2022;13:338-44.
crossref pmid
36. Mayorga V, Navarro R, Roldan V, Urtecho M, Tipe S, Calvert B, et al. Efficacy of lactoferrin supplementation in pediatric infections: a systematic review and meta-analysis. Biochem Cell Biol 2025;103:1-23.
crossref pmc
37. Eilat-Adar S, Kassem E, Sindiani M, Ben-Zaken S. IGF1 genetic polymorphism and the association between vitamin D status and BMI percentiles in children. Children (Basel) 2023;10:1610.
crossref pmid pmc
38. Hemmatyar A, Vafapour M, Talebi H, Dastgheib SA, Bahrami R, Pourkazemi M, et al. Association of IGF1R polymorphisms with idiopathic short stature in children: a metaanalysis. Res Sq [Preprint] 2025;[cite 2025 Jul 3]. Available from: https://doi.org/10.21203/rs.3.rs-5865273/v1.
crossref
39. Zhang Q, Bai B, Liu X, Miao C, Li H. Association of folate metabolism genes MTHFR and MTRR with multiple complex congenital malformation risk in Chinese population of Shanxi. Transl Pediatr 2014;3:259-67.
pmid pmc
40. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): checklist and explanation. Ann Intern Med 2018;169:467-73.
crossref pmid
41. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 2021;88:105906.
crossref pmid
42. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. Rev Panam Salud Publica 2022;46:e112.
crossref pmid pmc
TOOLS
Share :
Facebook Twitter Linked In Google+
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 3,267 View
  • 64 Download
Related articles in APEM


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
501-107, 30 Seocho-daero 74-gil, Seocho-gu, Seoul 06622, Republic of Korea
Tel: +82-2-3471-4268    Fax: +82-2-3471-4269    E-mail: editor@e-apem.org                

Copyright © 2026 by Korean Society of Pediatric Endocrinology.

Developed in M2PI

Close layer
prev next